LOW · NYSE
| FY2026 | FY2025 | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $86.29B | $83.67B | $86.38B | $97.06B | $96.25B | $89.60B | $72.15B | $71.31B |
| Cost of Revenue | $57.40B | $55.80B | $57.53B | $64.80B | $64.19B | $60.02B | $49.20B | $48.40B |
| Gross Profit | $28.89B | $27.88B | $28.84B | $32.26B | $32.06B | $29.57B | $22.94B | $22.91B |
| Selling, General & Administrative | $16.79B | $15.68B | $15.57B | $20.33B | $18.30B | $18.53B | $15.37B | $17.41B |
| Operating Income | $10.15B | $10.47B | $11.56B | $10.16B | $12.09B | $9.65B | $6.31B | $4.02B |
| Income Before Taxes | $8.75B | $9.15B | $10.18B | $9.04B | $11.21B | $7.74B | $5.62B | $3.39B |
| Provision for Income Taxes | $2.09B | $2.20B | $2.45B | $2.60B | $2.77B | $1.90B | $1.34B | $1.08B |
| Net Income | $6.65B | $6.96B | $7.73B | $6.44B | $8.44B | $5.83B | $4.28B | $2.31B |
| Basic EPS | $11.87 | $12.25 | $13.23 | $10.20 | $12.07 | $7.77 | $5.49 | $2.84 |
| Diluted EPS | $11.85 | $12.23 | $13.20 | $10.17 | $12.04 | $7.75 | $5.49 | $2.84 |
| Basic Shares Outstanding | 559.00M | 567.00M | 582.00M | 629.00M | 696.00M | 748.00M | 777.00M | 811.00M |
| Diluted Shares Outstanding | 560.00M | 568.00M | 584.00M | 631.00M | 699.00M | 750.00M | 778.00M | 812.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $12.46 | $12.33 | $12.65 | 15 | ↑0 ↓1 |
| Jan 2028 | $13.43 | $12.84 | $13.80 | 15 | ↑0 ↓1 |
| Jan 2029 | $14.71 | $14.34 | $15.30 | 6 | ↑0 ↓0 |
| Jan 2030 | $15.95 | $15.90 | $16.01 | 2 | ↑0 ↓0 |